Management of pain in patients with multiple health problems: A guide for the practicing physician

American Journal of Medicine

Volumn 105, Issue 1 B, 1998, Pages 53S-60S

  Ruoff, Gary ^a  

^a Westside Family Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE AGONIST; PARACETAMOL;

CHRONIC PAIN; CONFERENCE PAPER; DRUG EFFECT; DRUG USE; GASTROINTESTINAL DISEASE; HUMAN; NEPHROTOXICITY; PAIN ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 0032572552     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00074-6     Document Type: Conference Paper

References (30)

1. Caudill MA, Holman GH, Turk D. Effective ways to manage chronic pain. Patient Care. 1996:154-172.
2. Katz WA. Approach to the management of nonmalignant pain. Am J Med. 1996;101(suppl 1A):54S-63S.
3. Whelton A, Hamilton CW. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol. 1991; 31:588-598.
4. Conaway DC. Using NSAIDs safely in the elderly. Hosp Med. 1995;May:1-9.
5. Kendall BJ, Peura DA. NSAID-associated gastrointestinal damage and the elderly. Practical Gastroenterology. 1993; 17:13-29.
6. Roth SH. Nonsteroidal anti-inflammatory drugs: gastropathy, deaths, and medical practice. Ann Intern Med. 1988; 109:353-354.
7. Gurwitz JH, Avorn J, Bonn RL, et al. Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy. JAMA. 1994;272:781-786.
8. Henrich WL, Agodoa LE, Barrett B, et al. Analgesics and the kidney: summary and recommendations to the scientific advisory board of the National Kidney Foundation from an ad hoc committee of the National Kidney Foundation. Am J Kidney Dis. 1996;27:162-165.
9. Pincus T, Griffin M. Gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs: new insights from observational studies and functional status questionnaires. Am J Med. 1991;91:209-212.
10. Henry D, Dobson A, Turner C. Variability in the risk of major gastrointestinal complications from nonaspirin nonsteroidal anti-inflammatory drugs. Gastroenterology. 1993;105: 1078-1088.
11. Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal anti-inflammatory drugs. N Engl J Med. 1992;327:749-754.
12. Barrier CH, Hirschowitz BI. Controversies in the detection and management of nonsteroidal anti-inflammatory drug-induced side effects of the upper gastrointestinal tract. Arthritis Rheum. 1989;32:926-932.
13. Griffin MR, Piper JM, Daugherty JR, et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114: 257-263.
14. Levy M, Miller DR, Kaufman DW, et al. Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other non-narcotic analgesics. Arch Intern Med. 1988;148: 281-285.
15. Yost JH, Morgan CJ Jr. Cardiovascular effects of NSAIDs. J Musculoskel Med. 1994;11:22-34.
16. Benson GD. Hepatotoxicity following the use of antipyretic analgesics. Am J Med. 1983;75:85-93.
17. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 1993;153:477-484.
18. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? Ann Intern Med. 1994;121:289-300.
19. Weissmann G. NSAIDs: aspirin and aspirin-like drugs. In: Wyngaarden JB, Smith LH, Bennett JC, eds. Cecil Textbook of Medicine. 19th ed. Philadelphia: WB Saunders; 1995:114-118.
20. Bjorkman DJ. Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury. Am J Med. 1996;101(suppl 1A):25S-32S.
21. Hochberg MD, Altman RD, Clark, BM, et al. Guidelines for the medical management of osteoarthritis. Arthritis Rheum. 1995;38:1535-1546.
22. Ameer B, Greenblatt DJ. Acetaminophen. Ann Intern Med. 1977;87:202-209.
23. Strom BL. Adverse reactions to over-the-counter analgesics taken for therapeutic purposes. JAMA. 1994;272: 1866-1867.
24. Gibson TP. Pharmacokinetics, efficacy, and safety of analgesia with a focus on tramadol HCI. Am J Med. 1996; 101(suppl 1A):47S-53S.
25. Dalgin P. Comparison of tramadol and ibuprofen for the chronic pain of osteoarthritis. (Abstr.) Presented at American College of Rheumatology, Washington, DC; November 8-12, 1997.
26. Katz WA. The role of tramadol in the management of musculoskeletal pain. Today's Ther Trends. 1995;13:177-186.
27. Barkin RL. Alternative dosing for tramadol aids effectiveness. Formulary. 1995;30:542-543.
28. Gloth FM III. Concerns with chronic analgesic therapy in elderly patients. Am J Med. 1996;101(suppl 1A):19S-24S.
29. Tollison JW. Special considerations in pharmacologic pain management. Handbook of Pain Management. 2nd ed. Baltimore: Williams and Wilkins 1994:215-223.
30. Berndt S, Maier C, Schütz HW. Polymedication and medication compliance in patients with chronic nonmalignant pain. Pain. 1993;52:331-339.